ChemicalBook >> CAS DataBase List >>ticiliMuMab treMeliMuMab
ticiliMuMab treMeliMuMab
- CAS No.
- 742092-03-1
- Chemical Name:
- ticiliMuMab treMeliMuMab
- Synonyms
- EC 145;Vintafolide;KUZYSQSABONDME-QRLOMCMNSA-N;Vincaleukoblastin-23-oic acid, O4-deacetyl-, 2-[(2-mercaptoethoxy)carbonyl]hydrazide, disulfide with N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-γ-glutamyl-L-α-aspartyl-L-arginyl-L-α-aspartyl-L-α-aspartyl-L-cysteine
- CBNumber:
- CB72658206
- Molecular Formula:
- C86H109N21O26S2
- Molecular Weight:
- 1917.06
- MDL Number:
- MFCD11983099
- MOL File:
- 742092-03-1.mol
Last updated:2023-05-04 15:16:49
| Density | 1?+-.0.1 g/cm3(Predicted) |
|---|---|
| solubility | Soluble in DMSO |
| form | Powder |
| pka | 2.80±0.10(Predicted) |
| FDA UNII | 36O410ZD4I |
| NCI Drug Dictionary | vintafolide |
| ATC code | L01CA06 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS08,GHS07 |
|---|---|
| Signal word | Danger |
| Hazard statements | H315-H372-H335-H360-H340-H370 |
| Precautionary statements | P264-P280-P302+P352-P321-P332+P313-P362-P260-P264-P270-P314-P501-P260-P264-P270-P307+P311-P321-P405-P501 |
ticiliMuMab treMeliMuMab Preparation Products And Raw materials
Raw materials
Preparation Products
ticiliMuMab treMeliMuMab Suppliers
Global( 6)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| NCE Biomedical Co.,Ltd. | 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 | China | 1494 | 55 | |
| LETOPHARM LIMITED | +86-21-5821 5861 | sales@letopharm.com | China | 2384 | 58 |
| SPIRO PHARMA | eric_feng1954@126.com | China | 9254 | 55 | |
| Shanghai Easy CDMO Co.,Ltd | 021-61734564 | August@easycdmo.com | China | 10010 | 58 |
| ApexBio Technology | -- | sales@apexbt.com | United States | 6254 | 58 |
| Supplier | Advantage |
|---|---|
| NCE Biomedical Co.,Ltd. | 55 |
| LETOPHARM LIMITED | 58 |
| SPIRO PHARMA | 55 |
| Shanghai Easy CDMO Co.,Ltd | 58 |
| ApexBio Technology | 58 |
Vintafolide
EC 145
KUZYSQSABONDME-QRLOMCMNSA-N
Vincaleukoblastin-23-oic acid, O4-deacetyl-, 2-[(2-mercaptoethoxy)carbonyl]hydrazide, disulfide with N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-γ-glutamyl-L-α-aspartyl-L-arginyl-L-α-aspartyl-L-α-aspartyl-L-cysteine
742092-03-1
C86H109N21O26S2